Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
about
The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.Daclizumab: A Review in Relapsing Multiple Sclerosis.Immune Response to Seasonal Influenza Vaccine in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Long-term Daclizumab Beta: A Prospective, Open-Label, Single-Arm Study.Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.Daclizumab Therapy for Multiple Sclerosis.
P2860
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patients with MS under daclizu ...... onses to influenza vaccination
@ast
Patients with MS under daclizu ...... onses to influenza vaccination
@en
type
label
Patients with MS under daclizu ...... onses to influenza vaccination
@ast
Patients with MS under daclizu ...... onses to influenza vaccination
@en
prefLabel
Patients with MS under daclizu ...... onses to influenza vaccination
@ast
Patients with MS under daclizu ...... onses to influenza vaccination
@en
P2093
P2860
P1476
Patients with MS under daclizu ...... onses to influenza vaccination
@en
P2093
Andrew Blake
Bibiana Bielekova
Elena Romm
Hana Golding
Jody Manischewitz
Lisa R King
Paige Winokur
Tianxia Wu
Yen Chih Lin
P2860
P356
10.1212/NXI.0000000000000196
P577
2016-01-27T00:00:00Z